Cargando…

Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis

BACKGROUND: Bronchoalveolar lavage (BAL) is one of the fundamental examinations for the differential diagnosis of interstitial lung diseases (ILDs), and lymphocytosis strongly indicates alternative diagnoses rather than idiopathic pulmonary fibrosis. However, the BALF lymphocytosis is observed in se...

Descripción completa

Detalles Bibliográficos
Autores principales: Horimasu, Yasushi, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Masuda, Takeshi, Miyamoto, Shintaro, Nakashima, Taku, Iwamoto, Hiroshi, Fujitaka, Kazunori, Hamada, Hironobu, Hattori, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254956/
https://www.ncbi.nlm.nih.gov/pubmed/34217348
http://dx.doi.org/10.1186/s13023-021-01926-x
_version_ 1783717809636769792
author Horimasu, Yasushi
Yamaguchi, Kakuhiro
Sakamoto, Shinjiro
Masuda, Takeshi
Miyamoto, Shintaro
Nakashima, Taku
Iwamoto, Hiroshi
Fujitaka, Kazunori
Hamada, Hironobu
Hattori, Noboru
author_facet Horimasu, Yasushi
Yamaguchi, Kakuhiro
Sakamoto, Shinjiro
Masuda, Takeshi
Miyamoto, Shintaro
Nakashima, Taku
Iwamoto, Hiroshi
Fujitaka, Kazunori
Hamada, Hironobu
Hattori, Noboru
author_sort Horimasu, Yasushi
collection PubMed
description BACKGROUND: Bronchoalveolar lavage (BAL) is one of the fundamental examinations for the differential diagnosis of interstitial lung diseases (ILDs), and lymphocytosis strongly indicates alternative diagnoses rather than idiopathic pulmonary fibrosis. However, the BALF lymphocytosis is observed in several ILDs. We considered that quantitative evaluation of the BALF lymphocyte nuclear morphology would be useful in the differential diagnosis of ILDs with increased BALF lymphocyte fraction. RESULTS: One hundred and twenty-one patients with ILDs having increased BALF lymphocyte fraction were recruited (68 in the development cohort and 53 in the validation cohort). In the development cohort, BALF lymphocyte nuclei in sarcoidosis patients showed significantly smaller areas, shorter perimeters, lower radius ratios, and increased roundness than those of other ILD patients (p < 0.001 for each). Next, the fractions of lymphocytes with small areas, short perimeters, low radius ratios, and increased roundness, which were determined based on receiver operating characteristic (ROC) analyses-based thresholds, were demonstrated to be higher in sarcoidosis patients than in the other ILD patients (p < 0.001 for each). Furthermore, when we combined size-representing parameters with shape-representing parameters, the fraction of lymphocytes with small and round nuclei showed approximately 0.90 of area under the ROC curve in discriminating sarcoidosis both in the development cohort and the validation cohort. CONCLUSION: This study is the first to demonstrate the usefulness of quantitative parameters of BALF lymphocyte nuclear morphology as novel biomarkers for sarcoidosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01926-x.
format Online
Article
Text
id pubmed-8254956
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82549562021-07-06 Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis Horimasu, Yasushi Yamaguchi, Kakuhiro Sakamoto, Shinjiro Masuda, Takeshi Miyamoto, Shintaro Nakashima, Taku Iwamoto, Hiroshi Fujitaka, Kazunori Hamada, Hironobu Hattori, Noboru Orphanet J Rare Dis Research BACKGROUND: Bronchoalveolar lavage (BAL) is one of the fundamental examinations for the differential diagnosis of interstitial lung diseases (ILDs), and lymphocytosis strongly indicates alternative diagnoses rather than idiopathic pulmonary fibrosis. However, the BALF lymphocytosis is observed in several ILDs. We considered that quantitative evaluation of the BALF lymphocyte nuclear morphology would be useful in the differential diagnosis of ILDs with increased BALF lymphocyte fraction. RESULTS: One hundred and twenty-one patients with ILDs having increased BALF lymphocyte fraction were recruited (68 in the development cohort and 53 in the validation cohort). In the development cohort, BALF lymphocyte nuclei in sarcoidosis patients showed significantly smaller areas, shorter perimeters, lower radius ratios, and increased roundness than those of other ILD patients (p < 0.001 for each). Next, the fractions of lymphocytes with small areas, short perimeters, low radius ratios, and increased roundness, which were determined based on receiver operating characteristic (ROC) analyses-based thresholds, were demonstrated to be higher in sarcoidosis patients than in the other ILD patients (p < 0.001 for each). Furthermore, when we combined size-representing parameters with shape-representing parameters, the fraction of lymphocytes with small and round nuclei showed approximately 0.90 of area under the ROC curve in discriminating sarcoidosis both in the development cohort and the validation cohort. CONCLUSION: This study is the first to demonstrate the usefulness of quantitative parameters of BALF lymphocyte nuclear morphology as novel biomarkers for sarcoidosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01926-x. BioMed Central 2021-07-03 /pmc/articles/PMC8254956/ /pubmed/34217348 http://dx.doi.org/10.1186/s13023-021-01926-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Horimasu, Yasushi
Yamaguchi, Kakuhiro
Sakamoto, Shinjiro
Masuda, Takeshi
Miyamoto, Shintaro
Nakashima, Taku
Iwamoto, Hiroshi
Fujitaka, Kazunori
Hamada, Hironobu
Hattori, Noboru
Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
title Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
title_full Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
title_fullStr Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
title_full_unstemmed Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
title_short Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
title_sort quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254956/
https://www.ncbi.nlm.nih.gov/pubmed/34217348
http://dx.doi.org/10.1186/s13023-021-01926-x
work_keys_str_mv AT horimasuyasushi quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT yamaguchikakuhiro quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT sakamotoshinjiro quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT masudatakeshi quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT miyamotoshintaro quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT nakashimataku quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT iwamotohiroshi quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT fujitakakazunori quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT hamadahironobu quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis
AT hattorinoboru quantitativeparametersoflymphocytenuclearmorphologyinbronchoalveolarlavagefluidasnovelbiomarkersforsarcoidosis